Magnus

Device Royal Biologics
Total Payments
$16,982
Transactions
96
Doctors
42
Companies
5

Payment Trends by Year

Year Amount Transactions Doctors
2024 $296.82 12 6
2022 $735.09 4 3
2021 $10,383 7 3
2020 $3,019 34 20
2019 $2,532 38 16
2017 $15.72 1 1

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $10,250 3 60.4%
Food and Beverage $5,732 91 33.8%
Consulting Fee $1,000 2 5.9%

Payments by Type

Research
$10,250
3 transactions
General
$6,732
93 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Single Center Prospective Registry to Evaluate Use and Outcomes of Royal Biologics Products in Spinal Fusion Surgery Royal Biologics, Inc. $10,250 1

Top Doctors Receiving Payments for Magnus — Page 2

Doctor Specialty Location Total Records
, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Rockledge, FL $66.54 2
, PA Surgical Rockledge, FL $66.54 2
Javier Perez Fernandez Critical Care Medicine South Miami, FL $52.24 1
, MD Orthopaedic Surgery Brooklyn, NY $51.97 1
, MD Emergency Medicine Denver, CO $49.47 2
, MD Hospitalist Denver, CO $49.47 2
, MD Emergency Medicine Denver, CO $49.47 2
, MD Surgery Vail, CO $49.47 2
, MD Emergency Medicine Denver, CO $49.47 2
, MD Surgery Denver, CO $49.47 2
, M.D Diagnostic Radiology Scottsdale, AZ $24.59 1
, DPM Podiatrist Glen Cove, NY $23.25 1
, M.D Thoracic Surgery (Cardiothoracic Vascular Surgery) Baltimore, MD $17.91 1
, MD Trauma Surgery Melbourne, FL $16.21 1
, MD Orthopaedic Surgery Melbourne, FL $16.20 1
, MD Neurological Surgery Kankakee, IL $15.72 1
, MD Pediatric Dentistry Rutherford, NJ $14.70 1

About Magnus

Magnus is a device associated with $16,982 in payments to 42 healthcare providers, recorded across 96 transactions in the CMS Open Payments database. The primary manufacturer is Royal Biologics.

Payment data is available from 2017 to 2024. In 2024, $296.82 was paid across 12 transactions to 6 doctors.

The most common payment nature for Magnus is "Unspecified" ($10,250, 60.4% of total).

Magnus is associated with 1 research study, including "Single Center Prospective Registry to Evaluate Use and Outcomes of Royal Biologics Products in Spinal Fusion Surgery" ($10,250).